Clinical Outcomes in Secondary Hyperparathyroidism and the Potential Role of Calcimimetics

Cinacalcet, a type II calcimimetic agent that interacts with the calcium-sensing receptor on the parathyroid gland and increases its sensitivity to calcium, has proved an effective therapy for the treatment of the biochemical derangements that comprise uraemic secondary hyperparathyroidism. These pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunningham, John, Floege, Jürgen, London, Gérard, Rodriguez, Mariano, Shanahan, Catherine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421154/
https://www.ncbi.nlm.nih.gov/pubmed/25983954
http://dx.doi.org/10.1093/ndtplus/sfm042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421154/
https://www.ncbi.nlm.nih.gov/pubmed/25983954
http://dx.doi.org/10.1093/ndtplus/sfm042

Ejemplares similares